A new dimension in BPH management
Management of benign prostatic hyperplasia (BPH): The pharmacological actions of Himplasia inhibit the enzyme 5α-reductase, which results in increased levels of testosterone. Drugs that inhibit the 5α-reductase enzyme have been traditionally used in the management of BPH, prostate cancer and baldness. The drug significantly reduces prostatic weight, epithelial (the outer layer of cells that cover open surfaces on the body) height and stromal (connective tissue supporting the framework of an organ) proliferation.
Reduces the symptoms of BPH: Urinary tract infections, dysuria (painful urination), local and internal inflammation are the common symptoms of BPH. Himplasia has anti-inflammatory and antispasmodic properties that relieve BPH-induced inflammation and pain. Due to its antimicrobial property, the medicine prevents urinary tract infections which results due to urine stagnation in the body.
- Benign prostatic hyperplasia (abnormal proliferation of prostrate cells)
Small Caltrops (Gokshura) is useful in treating BPH, genitourinary infections, painful urination, hematuria and dysuria.
Cutch Tree (Puga) is chiefly responsible for inhibiting the 5α-reductase enzyme. This action blocks the conversion of testosterone to dihydrotestosterone, the major sex hormone in prostatic cells responsible for BPH.
Three-leaved Caper (Varuna) relieves post-prostatectomy atony of bladder and improves overall bladder tone. It exhibits strong anti-inflammatory action that soothes BPH-induced pain.
Directions for use:
Please consult your physician to prescribe the dosage that best suits your condition.
Available as a tablet.
Himplasia is not known to have any side effects if taken as per the prescribed dosage.
For information on clinical research Click here
The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.